Index
1 Market Overview of Oncology Based Molecular Diagnostic
1.1 Oncology Based Molecular Diagnostic Market Overview
1.1.1 Oncology Based Molecular Diagnostic Product Scope
1.1.2 Oncology Based Molecular Diagnostic Market Status and Outlook
1.2 Global Oncology Based Molecular Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oncology Based Molecular Diagnostic Market Size by Region (2018-2029)
1.4 Global Oncology Based Molecular Diagnostic Historic Market Size by Region (2018-2023)
1.5 Global Oncology Based Molecular Diagnostic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oncology Based Molecular Diagnostic Market Size (2018-2029)
1.6.1 North America Oncology Based Molecular Diagnostic Market Size (2018-2029)
1.6.2 Europe Oncology Based Molecular Diagnostic Market Size (2018-2029)
1.6.3 Asia-Pacific Oncology Based Molecular Diagnostic Market Size (2018-2029)
1.6.4 Latin America Oncology Based Molecular Diagnostic Market Size (2018-2029)
1.6.5 Middle East & Africa Oncology Based Molecular Diagnostic Market Size (2018-2029)
2 Oncology Based Molecular Diagnostic Market by Type
2.1 Introduction
2.1.1 Instruments
2.1.2 Reagents
2.2 Global Oncology Based Molecular Diagnostic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Type (2018-2023)
2.2.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oncology Based Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oncology Based Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oncology Based Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oncology Based Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oncology Based Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
3 Oncology Based Molecular Diagnostic Market Overview by Application
3.1 Introduction
3.1.1 Breast Cancer
3.1.2 Prostate Cancer
3.1.3 Colorectal Cancer
3.1.4 Cervical Cancer
3.1.5 Liver Cancer
3.1.6 Lung Cancer
3.1.7 Blood Cancer
3.1.8 Kidney Cancer
3.2 Global Oncology Based Molecular Diagnostic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Application (2018-2023)
3.2.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oncology Based Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oncology Based Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oncology Based Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oncology Based Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oncology Based Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
4 Oncology Based Molecular Diagnostic Competition Analysis by Players
4.1 Global Oncology Based Molecular Diagnostic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Based Molecular Diagnostic as of 2022)
4.3 Date of Key Players Enter into Oncology Based Molecular Diagnostic Market
4.4 Global Top Players Oncology Based Molecular Diagnostic Headquarters and Area Served
4.5 Key Players Oncology Based Molecular Diagnostic Product Solution and Service
4.6 Competitive Status
4.6.1 Oncology Based Molecular Diagnostic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Oncology Based Molecular Diagnostic Products, Services and Solutions
5.1.4 Abbott Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Bayer Healthcare
5.2.1 Bayer Healthcare Profile
5.2.2 Bayer Healthcare Main Business
5.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Products, Services and Solutions
5.2.4 Bayer Healthcare Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Healthcare Recent Developments
5.3 Beckton Dickinson
5.3.1 Beckton Dickinson Profile
5.3.2 Beckton Dickinson Main Business
5.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Products, Services and Solutions
5.3.4 Beckton Dickinson Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.3.5 Cepheid Recent Developments
5.4 Cepheid
5.4.1 Cepheid Profile
5.4.2 Cepheid Main Business
5.4.3 Cepheid Oncology Based Molecular Diagnostic Products, Services and Solutions
5.4.4 Cepheid Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.4.5 Cepheid Recent Developments
5.5 Dako
5.5.1 Dako Profile
5.5.2 Dako Main Business
5.5.3 Dako Oncology Based Molecular Diagnostic Products, Services and Solutions
5.5.4 Dako Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.5.5 Dako Recent Developments
5.6 Hologic
5.6.1 Hologic Profile
5.6.2 Hologic Main Business
5.6.3 Hologic Oncology Based Molecular Diagnostic Products, Services and Solutions
5.6.4 Hologic Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.6.5 Hologic Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen Oncology Based Molecular Diagnostic Products, Services and Solutions
5.7.4 Qiagen Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business
5.8.3 Roche Oncology Based Molecular Diagnostic Products, Services and Solutions
5.8.4 Roche Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Recent Developments
5.9 Siemens Healthineers
5.9.1 Siemens Healthineers Profile
5.9.2 Siemens Healthineers Main Business
5.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Products, Services and Solutions
5.9.4 Siemens Healthineers Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.9.5 Siemens Healthineers Recent Developments
5.10 Sysmex
5.10.1 Sysmex Profile
5.10.2 Sysmex Main Business
5.10.3 Sysmex Oncology Based Molecular Diagnostic Products, Services and Solutions
5.10.4 Sysmex Oncology Based Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.10.5 Sysmex Recent Developments
6 North America
6.1 North America Oncology Based Molecular Diagnostic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oncology Based Molecular Diagnostic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oncology Based Molecular Diagnostic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oncology Based Molecular Diagnostic Market Dynamics
11.1 Oncology Based Molecular Diagnostic Industry Trends
11.2 Oncology Based Molecular Diagnostic Market Drivers
11.3 Oncology Based Molecular Diagnostic Market Challenges
11.4 Oncology Based Molecular Diagnostic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List